{"schema_version":"secwatch.filing_event.v1","accession":"0001501134-24-000007","form_type":"8-K","ticker":null,"cik":"0001501134","company_name":"Invitae Corp","filed_at":"2024-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.355026+00:00","generated_at":"2026-06-06T20:37:31.495692+00:00","sec_items":["1.01","2.01","2.05","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Invitae sells reproductive health assets to Natera for up to $52.5M","bullets":["Upfront $10M cash; up to $20M litigation credits/cash from Natera v. ArcherDx case; up to $22.5M retention milestone.","Natera hires Invitae reproductive health sales reps; transitions carrier screening and NIPT customers.","Non-compete on testing services until March 2027; transition services through July 2024.","Workforce reduction; expects $44M annualized OpEx cash savings from sale, excluding severance.","Past damages cap of $20M for infringing sales in Natera v. ArcherDx case."],"urls":{"canonical":"https://secwatch.observer/filing/0001501134-24-000007","json":"https://secwatch.observer/filing/0001501134-24-000007.json","markdown":"https://secwatch.observer/filing/0001501134-24-000007.md","text":"https://secwatch.observer/filing/0001501134-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/0001501134-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/nvta-20240117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:37:31.495692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c5dbeaf9f0280c78767a5d331d8e1eef9eaf867","claim":"Invitae Corp completed a disposition involving Natera, Inc. for $10.0 million (closed 2024-01-17).","evidence_excerpt":"certain Invitae employees engaged in the reproductive health category. In consideration for the purchased assets, Natera (i) has made an upfront payment in cash in the amount of $10.0 million to Invitae and (ii) will make additional payments up to $42.5 million, which amount, if any, includes (a) the payment of cash and/or providing litigation-related credits in","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/0001501134-24-000007-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Natera, Inc."},{"label":"Consideration","value":"$10.0 million"},{"label":"Closing","value":"2024-01-17"}],"fact_type":"ma_transaction"},{"claim_id":"5955c3a1918bb45fe608f7898cf7e79da8e61bc8","claim":"Invitae Corp entered into Asset Purchase Agreement with Natera, Inc. valued at upfront payment $10.0 million; additional payments up to $42.5 million (including up to $20.0 millio (effective 2024-01-17).","evidence_excerpt":"On January 17, 2024, Invitae Corporation (the “Company”) entered into and subsequently closed an Asset Purchase Agreement (the “Agreement”) with Natera, Inc., a Delaware corporation (“Natera”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/0001501134-24-000007-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Natera, Inc."},{"label":"Value","value":"upfront payment $10.0 million; additional payments up to $42.5 million (including up to $20.0 millio"},{"label":"Effective","value":"2024-01-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}